[Federal Register Volume 76, Number 234 (Tuesday, December 6, 2011)]
[Proposed Rules]
[Pages 76096-76097]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-31225]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
21 CFR Part 1140
[Docket No. FDA-2011-N-0467]
RIN 0910-AG43
Non-Face-to-Face Sale and Distribution of Tobacco Products and
Advertising, Promotion, and Marketing of Tobacco Products; Extension of
Comment Period
AGENCY: Food and Drug Administration, HHS.
ACTION: Advance notice of proposed rulemaking; extension of comment
period.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is extending the
comment period until January 19, 2012, for an advance notice of
proposed rulemaking (ANPRM) that was published in the Federal Register
of September 9, 2011 (76 FR 55835). In that document, FDA requested
comments, data, research, or other information related to non-face-to-
face sale and distribution of tobacco products; the advertising,
promotion, and marketing of such products; and the advertising of
tobacco products via the Internet, email, direct mail, telephone, smart
phones, and other communication technologies that can be directed to
specific recipients. The Agency is extending the comment period in
response to a request to give interested parties additional time to
comment.
DATES: Submit either electronic or written comments by January 19,
2012.
ADDRESSES: You may submit comments, identified by Docket No. FDA-2011-
N-0467 and/or RIN number 0910-AG43, by any of the following methods:
Electronic Submissions
Submit electronic comments in the following way:
Federal eRulemaking Portal: http://www.regulations.gov.
Follow the instructions for submitting comments.
Written Submissions
Submit written submissions in the following ways:
FAX: (301) 827-6870.
Mail/Hand delivery/Courier (for paper, disk, or CD-ROM
submissions): Division of Dockets Management (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
Instructions: All submissions received must include the Agency name
and Docket No. FDA-2011-N-0467 and Regulatory Information Number (RIN
0910-AG43) for this rulemaking. All comments received may be posted
without change to http://www.regulations.gov, including any personal
information provided. For additional information on submitting
comments, see the ``Comments'' heading of the SUPPLEMENTARY INFORMATION
section of this document.
Docket: For access to the docket to read background documents or
comments received, go to http://www.regulations.gov and insert the
docket number, found in brackets in the heading of this document, into
the ``Search'' box and follow the prompts and/or go to the Division of
Dockets Management, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: Beth Buckler, Center for Tobacco
Products, Food and Drug Administration, 9200 Corporate Blvd.,
Rockville, MD 20850-3229, (877) 287-1373, [email protected].
SUPPLEMENTARY INFORMATION:
I. Background
In the Federal Register of September 9, 2011 (76 FR 55835), FDA
issued an ANPRM to obtain information related to the regulation of non-
face-to-face sale and distribution of tobacco products and the
advertising, promotion, and marketing of tobacco products. FDA took
this action as part of its implementation of the Family Smoking
Prevention and Tobacco Control Act (Pub. L. 111-31, 123 Stat. 1776).
FDA requested comments, data, research, or other information related to
non-face-to-face sale and distribution of tobacco products; the
advertising, promotion, and marketing of such products; and the
advertising of tobacco products via the Internet, email, direct mail,
telephone, smart phones, and other communication technologies that can
be directed to specific recipients. FDA intends to use the information
submitted in response to the ANPRM to inform its regulation of the sale
and distribution of tobacco products through a non-face-to-face
exchange and the advertising, promotion, and marketing of tobacco
products. FDA provided a 90-day comment period (i.e., until December 8,
2011) for the ANPRM.
[[Page 76097]]
FDA has received a request to extend the comment period. The
request stated that additional time is needed to coordinate factual
information and policy positions with a large number of States on
several of the questions in the ANPRM. The request noted that their
comments will be more thorough and of more assistance to FDA if more
time is available to develop them.
FDA has considered the request and is extending the comment period
an additional 6 weeks, until January 19, 2012. We believe that the
additional time will provide interested parties sufficient time to
submit comments on the ANPRM.
II. Comments
Interested persons may submit to the Division of Dockets Management
(see ADDRESSES) either electronic or written comments regarding this
ANPRM. It is only necessary to send one set of comments. It is no
longer necessary to send two copies of mailed comments. Identify
comments with the docket number found in brackets in the heading of
this document. Received comments may be seen in the Division of Dockets
Management between 9 a.m. and 4 p.m., Monday through Friday.
Dated: December 1, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-31225 Filed 12-5-11; 8:45 am]
BILLING CODE 4160-01-P